Form 8-K - Current report:
SEC Accession No. 0001477932-19-007274
Filing Date
2019-12-23
Accepted
2019-12-23 16:10:11
Documents
4
Period of Report
2019-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K imle_8k.htm 8-K 15228
2 SERIES A-1 PREFERRED STOCK PURCHASE AGREEMENT imle_101.htm EX-10.1 90674
3 PRESS RELEASE imle_991.htm EX-99.1 5132
4 imle_991img1.jpg GRAPHIC 14234
  Complete submission text file 0001477932-19-007274.txt   132111
Mailing Address 400 N. TUSTIN AVE. SUITE 225 SANTA ANA CA 92705
Business Address 400 N. TUSTIN AVE. SUITE 225 SANTA ANA CA 92705 714-667-7139
TransBiotec, Inc. (Filer) CIK: 0001425627 (see all company filings)

EIN.: 260731818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53316 | Film No.: 191306107
SIC: 2721 Periodicals: Publishing or Publishing & Printing